Merit Medical Systems | MMSI - Ebitda

Aktienkurs
68.58
Täglich Wechseln
-0.03 -0.04%
Monatlich
0.69%
Jährlich
-27.51%
Q2 Prognose
67.11




Ebitda Veränderung Datum
3M USD 1.41B 267M 2025-12
Abbott USD 3.27B 178M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
ICU Medical USD 98.19M 27.67M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Olympus JPY 45.72B 4.58B 2025-12
Pfizer USD 6.08B 351M 2025-09
STAAR Surgical USD -159K 34.78M 2025-12
Stryker USD 1.67B 206M 2025-09
Surmodics USD 3.43M 1.9M 2025-06
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12